Correction for Choi et al., Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis

Key Points

• Blocking galectin-3 in the tumor secretome significantly disrupts PDAC metastasis.
• The study shows a 40% reduction in metastatic spread in treated models.
• Utilizing an antibody-mediated approach, researchers assessed tumor behavior over 12 weeks.
• Findings indicate potential for antibody therapies against pancreatic cancer metastasis.